349 related articles for article (PubMed ID: 3080466)
1. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
Sopelak VM; Collins RL; Hodgen GD
J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
[TBL] [Abstract][Full Text] [Related]
2. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
[TBL] [Abstract][Full Text] [Related]
3. Effect of the timing of controlled internal drug-releasing device insertion on the gonadotropin-releasing hormone-induced luteinizing hormone surge and ovulatory response.
Perry GA; Perry BL
J Anim Sci; 2009 Dec; 87(12):3983-90. PubMed ID: 19684266
[TBL] [Abstract][Full Text] [Related]
4. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle.
Filicori M; Flamigni C; Campaniello E; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A; Valdiserri A
Am J Physiol; 1989 Dec; 257(6 Pt 1):E930-6. PubMed ID: 2514600
[TBL] [Abstract][Full Text] [Related]
6. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
7. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells.
Chandrasekher YA; Brenner RM; Molskness TA; Yu Q; Stouffer RL
J Clin Endocrinol Metab; 1991 Sep; 73(3):584-9. PubMed ID: 1908482
[TBL] [Abstract][Full Text] [Related]
8. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe.
Mais V; Kazer RR; Cetel NS; Rivier J; Vale W; Yen SS
J Clin Endocrinol Metab; 1986 Jun; 62(6):1250-5. PubMed ID: 3084538
[TBL] [Abstract][Full Text] [Related]
9. Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge.
Chandrasekher YA; Hutchison JS; Zelinski-Wooten MB; Hess DL; Wolf DP; Stouffer RL
J Clin Endocrinol Metab; 1994 Jul; 79(1):298-306. PubMed ID: 8027245
[TBL] [Abstract][Full Text] [Related]
10. Ovulation inhibition by administration of weekly gonadotropin-releasing hormone antagonist.
Kenigsberg D; Hodgen GD
J Clin Endocrinol Metab; 1986 Apr; 62(4):734-8. PubMed ID: 3081571
[TBL] [Abstract][Full Text] [Related]
11. Ovulatory follicle dysfunction in lactating dairy cows after treatment with Folltropin-V at the onset of luteolysis.
Giordano JO; Edwards JL; Di Croce FA; Roper D; Rohrbach NR; Saxton AM; Schuenemann GM; Prado TM; Schrick FN
Theriogenology; 2013 May; 79(8):1210-7. PubMed ID: 23534994
[TBL] [Abstract][Full Text] [Related]
12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
13. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
[TBL] [Abstract][Full Text] [Related]
14. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
Richardson DW; Gordon K; Billiar RB; Little AB
Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
[TBL] [Abstract][Full Text] [Related]
15. Effect of reduced luteinizing hormone concentrations on corpus luteum function during the menstrual cycle of rhesus monkeys.
Zeleznik AJ; Little-Ihrig LL
Endocrinology; 1990 May; 126(5):2237-44. PubMed ID: 2184013
[TBL] [Abstract][Full Text] [Related]
16. Induction of follicular development and ovulation in seasonally acyclic mares using gonadotrophin-releasing hormones and progesterone.
Evans MJ; Irvine CH
J Reprod Fertil Suppl; 1979; (27):113-21. PubMed ID: 383982
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
19. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
Santoro N; Wierman ME; Filicori M; Waldstreicher J; Crowley WF
J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
[TBL] [Abstract][Full Text] [Related]
20. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
